33m
Seattle biotech looks to raise up to $288 million amid plans to spin out immune medicine business
The company said in a regulatory filing that separating its two business lines "would enable each to pursue its distinct ...
User Agreement; Privacy Policy; Ad Choices; Site Map © 2026 American City Business Journals. All rights reserved. Use of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results